Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Grant supports matriptase inhibitor development at Curacyte

Dec. 12, 2003

Schering AG researchers claim new PLK inhibitors for cancer and other uses

Dec. 12, 2003

Palifermin improves quality of life in cancer patients with oral mucositis

Dec. 12, 2003

New PARP inhibitors described by KuDOS and Maybridge scientists

Dec. 12, 2003

BMS-247550 in metastatic breast cancer

Dec. 12, 2003

Safety and clinical efficacy of GW-572016 in advanced breast cancer

Dec. 12, 2003

Disease stabilization in phase II multiple myeloma study of Panzem

Dec. 12, 2003

Vion enters research and option agreement for novel anticancer compounds

Dec. 12, 2003

Novel inhibitor of Stat3 activation with activity against hematological malignancies

Dec. 11, 2003

Antitumor efficacy of Bay-59-8862 in metastatic breast cancer

Dec. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...